Hims & Hers Health, Inc. (HIMS) stock
HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/30171% above fair value
$17.05−0.50 (-2.85%)
Close on Nov 18, 2026Market cap $3.98BP/E –Yield –
Hims & Hers Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Hims & Hers Health's operating income for the twelve months ending Jun 30, 2026 was -$154.52M, down 223.0% year over year. For fiscal 2025 it was $105.61M, up 70.6% from the year before. The highest annual figure on record is $105.61M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $105.61M | +70.6% |
| FY2024 | Dec 31, 2024 | $61.90M | – |
| FY2023 | Dec 31, 2023 | -$29.45M | – |
| FY2022 | Dec 31, 2022 | -$68.70M | – |
| FY2021 | Dec 31, 2021 | -$115.04M | – |
| FY2020 | Dec 31, 2020 | -$15.14M | – |
| FY2019 | Dec 31, 2019 | -$74.41M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$97.19M | -463.7% |
| Q1 FY2026 | Mar 31, 2026 | -$78.32M | -235.3% |
| Q4 FY2025 | Dec 31, 2025 | $9.19M | -50.6% |
| Q3 FY2025 | Sep 30, 2025 | $11.81M | -47.2% |
| Q2 FY2025 | Jun 30, 2025 | $26.72M | +142.3% |
| Q1 FY2025 | Mar 31, 2025 | $57.90M | +484.6% |
| Q4 FY2024 | Dec 31, 2024 | $18.60M | – |
| Q3 FY2024 | Sep 30, 2024 | $22.37M | – |
| Q2 FY2024 | Jun 30, 2024 | $11.03M | – |
| Q1 FY2024 | Mar 31, 2024 | $9.90M | – |
| Q4 FY2023 | Dec 31, 2023 | -$400.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.55M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.24M | – |
| Q1 FY2023 | Mar 31, 2023 | -$11.26M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.61M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.98M | – |
| Q2 FY2022 | Jun 30, 2022 | -$20.19M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.92M | – |
| Q4 FY2021 | Dec 31, 2021 | -$21.57M | – |
| Q3 FY2021 | Sep 30, 2021 | -$27.66M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.41M | – |
| Q1 FY2021 | Mar 31, 2021 | -$48.41M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.63M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.32M | – |
| Q2 FY2020 | Jun 30, 2020 | -$979.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.22M | – |
| Q3 FY2019 | Sep 30, 2019 | -$449.94K | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.61K | – |
See a number that looks wrong?